Tredaptive cholesterol-lowering drug

Tredaptive cholesterol-lowering drug

C007/6228 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 53.2MB

Downloadable file size: 1.1MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Tredaptive cholesterol-lowering drug tablet and packaging. This drug contains nicotinic acid (niacin) and laropiprant. Niacin is a lipid (fat) lowering agent that reduces the overall amount of cholesterol, free fatty acids and triglycerides in the blood. It prevents the breakdown of fats in adipose tissue (fat storage tissue) including the breakdown of the precursor of low density lipoprotein (LDL), also known as 'bad' cholesterol. High blood levels of LDL lead to atherosclerosis, causing increased blood pressure and heart disease. Laropiprant is included to prevent skin flushing, a side effect of niacin.

Release details: Model release not required. Property release not available.

Keywords: b3, bad cholesterol, cardiovascular disease, cholesterol, cholesterol lowering, drug, dyslipidaemia, dyslipidemia, healthcare, heart disease, hypercholesterolaemia, hypercholesterolemia, laropiprant, ldl, lipid lowering, low density lipoprotein, medical, medicine, niacin, nicotinic acid, packaging, packet, pharmaceutics, pharmacological, pharmacology, tablet, treatment, tredaptive

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.